Pyxis Tankers beat estimated earnings by 5.26%, reporting an EPS of $0.2 versus an estimate of $0.19. Revenue was down $1.50 million from the same period last year. During the previous quarter, the ...
As of April 3 at 6:32:00 p.m. UTC. Market Open. A ratio that indicates liquidity. Higher ratios suggest the asset is more actively traded and easier to buy/sell near its true value. Lower ratios may ...
— PYX-201 achieved a confirmed 50% ORR by RECIST 1.1 including one Complete Response and 100% Disease Control Rate in six heavily pretreated HNSCC patients, supporting differentiated mono and ...
BOSTON, May 30, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, today ...
Pyxis Tankers Inc (NASDAQ:PXS) reported a solid financial performance with strong revenues and profitability driven by supportive market conditions. The company successfully expanded into the dry-bulk ...
Pyxis Tankers Inc (NASDAQ:PXS) chairman and CEO Valentios (Eddie) Valentis speaks to Thomas Warner from Proactive about how the tanker operator has been performing since his last Proactive appearance ...
Pyxis Oncology (NASDAQ:PYXS), a biopharmaceutical company specializing in the development of antibody-drug conjugates (ADCs) for cancer treatment, has been garnering attention from investors and ...
Discover who owns Pyxis Tankers Inc. Access the ownership overview, view the top Pyxis Tankers Inc shareholders, institutional holders, and leading mutual fund investors. Understand the key ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results